Life ScienceCompany
Double Helix Biotechnology Development Ownership
Who owns Double Helix Biotechnology Development?
Double Helix Biotechnology Development is owned by The Interpublic Group of Companies. It was acquired on June 26, 2012.
Double Helix Biotechnology Development Business Overview
Where is Double Helix Biotechnology Development headquartered?
Double Helix Biotechnology Development is headquartered in London, United Kingdom.
What sector is Double Helix Biotechnology Development in?
Double Helix Biotechnology Development is a life science company.
Life Science M&A Summary in 2012
Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.
Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.